1910 Genetics
Advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation.
37 employees · est. 2018 · Boston, United States
XtalPi Inc.
Dedicated to building a technology platform using AI and robotics to drive innovation in multiple industries.
395 employees · est. 2014 · Cambridge, United States
XtalPi Inc. is the older company (2018 vs 2014); XtalPi Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | 1910 Genetics | XtalPi Inc. |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2014 older |
| Headquarters | ||
| Headquarters | Boston, United States | Cambridge, United States |
| Employees | ||
| Employees | 37 | 395 larger |
| Industry | ||
| Industry | AI, Biotechnology, Health and Wellness | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series Unknown | IPO |
| Total Funding | ||
| Total Funding | $26.65M | $1.76B |
| Funding Rounds | ||
| Funding Rounds | 5 | 11 |
| Services | ||
| Services | AI-enabled drug discovery, Integration of AI models with lab automation, Macrocyclic peptide drug development, Predictive modeling for CNS penetration | AI & Quantum Physics Integration, Automated Experimental Robotics, Pharmaceutical Patent Analysis Tools, Advanced Molecular Synthesis Platforms, Crystalline Structure Analysis, High-Accuracy Energy Calculations |
| Target Customers | ||
| Target Customers | Biotech companies, Pharmaceutical companies, Research institutions, Drug development organizations | Pharmaceutical Companies, Biotech Researchers, Chemical Industry Professionals, Material Science Innovators, AI and Machine Learning Enthusiasts, Academic and Research Institutions |
| Taxonomy | ||
| Taxonomy | AI-driven Drug Discovery, Small Molecule Therapeutics, Large Molecule Therapeutics, Multimodal AI Platform, Laboratory Automation, Neurological Disease Research, Autoimmune Disease Research, Cancer Therapy Development, Computational Biology, Biotech Innovation, Pharmaceutical Partnerships, Data-driven Drug Development, Biological Automation, Protein Therapeutics | AI-Powered Drug Discovery, Quantum Physics For R&D, Robotics In Drug Development, Cloud Supercomputing, In Silico Drug Development, Wet Lab Automation, Integrated Technology Platform, Iterative Feedback Loop, Pharmaceutical Innovation, Experimental Data Integration, Computing-Driven Pharmacology, Therapeutics Development, Biotech R&D, AI4Science |
| Website | ||
| Website | 1910genetics.com | xtalpi.com |
About 1910 Genetics
1910 Genetics is a pioneering biotechnology company established in 2018, setting itself apart by utilizing a multimodal AI platform to advance both small and large molecule drug discovery. The company integrates AI with three proprietary datasets—computational, wet lab proxy biological, and wet lab...
About XtalPi Inc.
XtalPi Inc., founded in 2014, stands at the forefront of the biotechnology and pharmaceutical industries with a focused mission to redefine drug discovery. The company leverages a unique fusion of quantum physics, AI, and robotics to accelerate and enhance drug development, aiming to improve speed,...
We will tell you when either one moves
BounceWatch watches 1910 Genetics and XtalPi Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at 1910 Genetics and XtalPi Inc. — by email.
Frequently Asked Questions
Compare 1910 Genetics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at 1910 Genetics on 15 Jun 2026, and XtalPi Inc. on 23 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
